ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,782Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 298

$636K Total Retail Price of All Prescriptions

Rank: 12 out of 298

372 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,811 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 545 428 1 1
OMEPRAZOLE 507 358 2 3
SIMVASTATIN 396 294 3 2
AMLODIPINE BESYLATE 327 251 4 6
FUROSEMIDE 315 254 5 5
HYDROCODONE-ACETAMINOPHEN 307 165 S3 6 8
LISINOPRIL 279 182 7 4
SERTRALINE HCL 222 165 8 19
WARFARIN SODIUM 222 140 8 7
METOPROLOL SUCCINATE 183 135 10 12
QUETIAPINE FUMARATE 175 128 11 68
HYDROCHLOROTHIAZIDE 169 135 12 13
GABAPENTIN 150 71 13 20
CITALOPRAM HBR 149 125 14 17
ALENDRONATE SODIUM 147 109 15 21
POLYETHYLENE GLYCOL 3350 140 79 16 29
SPIRONOLACTONE 139 115 17 34
CARVEDILOL 134 109 18 23
METOPROLOL TARTRATE 131 110 19 9
ATORVASTATIN CALCIUM 129 87 20 14
TRAMADOL HCL 123 78 21 15
PREDNISONE 119 89 22 33
POTASSIUM CHLORIDE 119 96 22 11
ATENOLOL 113 112 24 16
NAMENDA 113 113 24 35
TRAZODONE HCL 109 60 26 39
FENOFIBRATE 106 79 27 62
FLUOXETINE HCL 105 61 28 50
RISPERIDONE 103 63 29 54
DONEPEZIL HCL 102 94 30 22
NEXIUM 97 49 31 40
METFORMIN HCL ER 91 33 32 57
METFORMIN HCL 86 63 33 10
FLUTICASONE PROPIONATE 83 54 34 38
RANITIDINE HCL 79 61 35 59
ALLOPURINOL 77 57 36 28
DIGOXIN 77 53 36 27
ZOLPIDEM TARTRATE 75 38 38 25
MELOXICAM 71 24 39 41
LOSARTAN POTASSIUM 69 53 40 18
AMLODIPINE BESYLATE-BENAZEPRIL 68 68 41 98
BENAZEPRIL HCL 66 42 42 52
PRAVASTATIN SODIUM 66 47 42 31
GLIMEPIRIDE 66 55 42 60
SEROQUEL 65 51 45 215
PROPRANOLOL HCL 64 35 46 85
PAROXETINE HCL 60 42 47 48
ALBUTEROL SULFATE 59 37 48 75
PROAIR HFA 59 34 48 96
CYCLOBENZAPRINE HCL 59 21 R 48 100
BUPROPION XL 58 34 51 166
ESCITALOPRAM OXALATE 57 35 52 89
MIRTAZAPINE 54 28 53 37
TAMSULOSIN HCL 52 47 54 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.